Document is current
Any future updates will be listed below
-
Authors
Moore, Seth M.
Gawron, Joseph
Stevens, Mckayla
Marziali, Leandro N.
Buys, Emmanuel S.
Milne, G. Todd
Feltri, Maria Laura
VerPlank, Jordan J.S. https://orcid.org/0000-0002-4411-2659
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (5R01 NS045630)
National Institute of Neurological Disorders and Stroke (F30NS125928)
Charcot-Marie-Tooth Association (Charcot-Marie-Tooth Association)
- License Information
-
More Information
Article History
Received: 29 April 2024
Revised: 27 August 2024
Accepted: 23 September 2024
First Online: 14 October 2024
Declarations
:
: Management of the mouse colony and all experiments involving mice were conducted in strict adherence to the protocols approved by the Institutional Animal Care and Use Committees (IACUC) of the Roswell Park Cancer Institute and the State University of New York at Buffalo.
: The opinions and assertions expressed herein are those of the authors and do not reflect the official policy or position of the Uniformed Services University of the Health Sciences or the Department of Defense.
: Not applicable.
: GTM and ESB were employees of Cyclerion Therapeutics and may own stock. All other authors report no conflicts of interest.
